v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 5,320 $ 24,123
Accounts receivable, net 7,397 6,868
Inventory, net 19,881 19,064
Other current assets 3,758 4,615
Total current assets 36,356 54,670
Property and equipment, net 10,701 10,753
Capitalized software, net 5,074 4,525
Goodwill 5,833 5,833
Intangible assets, net 3,957 4,266
Operating lease right-of-use assets 2,558 2,701
Deferred tax assets, net 24,481 24,793
Other non-current assets 72 72
Total assets 89,032 107,613
Current liabilities    
Accounts payable 8,236 6,826
Accrued expenses 10,282 9,806
Term loan, current 6,250 6,250
Deferred revenue, current 2,848 3,017
Operating lease liabilities, current 610 592
Share repurchase liabilities 0 18,500
Total current liabilities 28,226 44,991
Term loan, net of current portion 94,425 95,782
Revolving loans 5,000 5,000
Deferred revenue, net of current portion 922 1,097
Operating lease liabilities, net of current portion 2,137 2,298
Other non-current liability 124 344
TRA liability 4,190 4,386
Earnout liabilities 1,963 4,112
Total liabilities 136,987 158,010
Commitments and contingencies (See Note 18)
Stockholders' Deficit    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued or outstanding as of March 31, 2026 and December 31, 2025, respectively
Additional paid-in capital 0 0
Accumulated deficit (46,032) (49,549)
Accumulated other comprehensive loss (27) (29)
Treasury stock, at cost (10,036) (8,965)
biote Corp.'s stockholders' deficit (56,091) (58,539)
Noncontrolling interest 8,136 8,142
Total stockholders' deficit (47,955) (50,397)
Total liabilities and stockholders' deficit 89,032 107,613
Class A Common Stock    
Stockholders' Deficit    
Common stock value 3 3
Class V Common Stock    
Stockholders' Deficit    
Common stock value $ 1 $ 1